ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Serum Gonadotrophin for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-27K16946
Home | Market Reports | Health| Pharmacy
Global Serum Gonadotrophin for Injection Market Research Report 2024
BUY CHAPTERS

Global Serum Gonadotrophin for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-27K16946
Report
November 2025
Pages:135
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
MSD Animal Health
Ceva Santé Animale
Bioveta
Ningbo Second Hormone Factory
Syntex SA
Ningbo Sansheng Biological Technology
Chifeng Bo-en Pharmaceutical
Guangzhou Vbio-Pharma
JALLY
Ningbo Creator Animal Pharmaceutical

Serum Gonadotrophin for Injection Market Size

The global Serum Gonadotrophin for Injection market is projected to grow from US$ 269 million in 2024 to US$ 372 million by 2031, at a CAGR of 4.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Serum Gonadotrophin for Injection Market

Serum Gonadotrophin for Injection Market

Serum gonadotropin for injection is a hormone drug whose main component is pregnant mare serum gonadotropin (PMSG). The action of serum gonadotropin is similar to the action of Follicle- Stimulating Hormone (FSH), which is produced by the animals' anterior pituitary gland. It stimulates the follicles of the ovaries to produce mature ova (eggs), and it promotes the outward signs of estrus (heat).
From a downstream perspective, Pig accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Serum Gonadotrophin for Injection leading manufacturers including MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with MSD Animal Health leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Serum Gonadotrophin for Injection market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Serum Gonadotrophin for Injection Market Report

Report Metric Details
Report Name Serum Gonadotrophin for Injection Market
Accounted market size in 2024 US$ 269 million
Forecasted market size in 2031 US$ 372 million
CAGR 4.8%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • 1000 IU/Unit
  • 5000 IU/Unit
  • Others
Segment by Application
  • Pig
  • Cattle
  • Sheep
  • Horse
  • Other Animals
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Serum Gonadotrophin for Injection study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Serum Gonadotrophin for Injection Market growing?

Ans: The Serum Gonadotrophin for Injection Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Serum Gonadotrophin for Injection Market size in 2031?

Ans: The Serum Gonadotrophin for Injection Market size in 2031 will be US$ 372 million.

Who are the main players in the Serum Gonadotrophin for Injection Market report?

Ans: The main players in the Serum Gonadotrophin for Injection Market are MSD Animal Health, Ceva Santé Animale, Syntex SA, Bioveta, Ningbo Sansheng Biological Technology, Ningbo Second Hormone Factory, Chifeng Bo-en Pharmaceutical, Guangzhou Vbio-Pharma, JALLY, Ningbo Creator Animal Pharmaceutical

What are the Application segmentation covered in the Serum Gonadotrophin for Injection Market report?

Ans: The Applications covered in the Serum Gonadotrophin for Injection Market report are Pig, Cattle, Sheep, Horse, Other Animals

What are the Type segmentation covered in the Serum Gonadotrophin for Injection Market report?

Ans: The Types covered in the Serum Gonadotrophin for Injection Market report are 1000 IU/Unit, 5000 IU/Unit, Others

1 Study Coverage
1.1 Introduction to Serum Gonadotrophin for Injection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Serum Gonadotrophin for Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 1000 IU/Unit
1.2.3 5000 IU/Unit
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Serum Gonadotrophin for Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pig
1.3.3 Cattle
1.3.4 Sheep
1.3.5 Horse
1.3.6 Other Animals
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Serum Gonadotrophin for Injection Revenue Estimates and Forecasts 2020-2031
2.2 Global Serum Gonadotrophin for Injection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Serum Gonadotrophin for Injection Sales Estimates and Forecasts 2020-2031
2.4 Global Serum Gonadotrophin for Injection Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Serum Gonadotrophin for Injection Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Serum Gonadotrophin for Injection Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 1000 IU/Unit Market Size by Manufacturers
3.5.2 5000 IU/Unit Market Size by Manufacturers
3.5.3 Others Market Size by Manufacturers
3.6 Global Serum Gonadotrophin for Injection Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Serum Gonadotrophin for Injection Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Serum Gonadotrophin for Injection Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Serum Gonadotrophin for Injection Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Serum Gonadotrophin for Injection Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Serum Gonadotrophin for Injection Sales and Revenue by Type (2020-2031)
6.4 North America Serum Gonadotrophin for Injection Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Serum Gonadotrophin for Injection Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Serum Gonadotrophin for Injection Sales and Revenue by Type (2020-2031)
7.4 Europe Serum Gonadotrophin for Injection Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Serum Gonadotrophin for Injection Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Serum Gonadotrophin for Injection Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Serum Gonadotrophin for Injection Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Serum Gonadotrophin for Injection Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Serum Gonadotrophin for Injection Sales and Revenue by Type (2020-2031)
9.4 Central and South America Serum Gonadotrophin for Injection Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Serum Gonadotrophin for Injection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Serum Gonadotrophin for Injection Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Serum Gonadotrophin for Injection Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Serum Gonadotrophin for Injection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 MSD Animal Health
11.1.1 MSD Animal Health Corporation Information
11.1.2 MSD Animal Health Business Overview
11.1.3 MSD Animal Health Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.1.4 MSD Animal Health Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 MSD Animal Health Serum Gonadotrophin for Injection Sales by Product in 2024
11.1.6 MSD Animal Health Serum Gonadotrophin for Injection Sales by Application in 2024
11.1.7 MSD Animal Health Serum Gonadotrophin for Injection Sales by Geographic Area in 2024
11.1.8 MSD Animal Health Serum Gonadotrophin for Injection SWOT Analysis
11.1.9 MSD Animal Health Recent Developments
11.2 Ceva Santé Animale
11.2.1 Ceva Santé Animale Corporation Information
11.2.2 Ceva Santé Animale Business Overview
11.2.3 Ceva Santé Animale Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.2.4 Ceva Santé Animale Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Ceva Santé Animale Serum Gonadotrophin for Injection Sales by Product in 2024
11.2.6 Ceva Santé Animale Serum Gonadotrophin for Injection Sales by Application in 2024
11.2.7 Ceva Santé Animale Serum Gonadotrophin for Injection Sales by Geographic Area in 2024
11.2.8 Ceva Santé Animale Serum Gonadotrophin for Injection SWOT Analysis
11.2.9 Ceva Santé Animale Recent Developments
11.3 Syntex SA
11.3.1 Syntex SA Corporation Information
11.3.2 Syntex SA Business Overview
11.3.3 Syntex SA Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.3.4 Syntex SA Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Syntex SA Serum Gonadotrophin for Injection Sales by Product in 2024
11.3.6 Syntex SA Serum Gonadotrophin for Injection Sales by Application in 2024
11.3.7 Syntex SA Serum Gonadotrophin for Injection Sales by Geographic Area in 2024
11.3.8 Syntex SA Serum Gonadotrophin for Injection SWOT Analysis
11.3.9 Syntex SA Recent Developments
11.4 Bioveta
11.4.1 Bioveta Corporation Information
11.4.2 Bioveta Business Overview
11.4.3 Bioveta Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.4.4 Bioveta Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Bioveta Serum Gonadotrophin for Injection Sales by Product in 2024
11.4.6 Bioveta Serum Gonadotrophin for Injection Sales by Application in 2024
11.4.7 Bioveta Serum Gonadotrophin for Injection Sales by Geographic Area in 2024
11.4.8 Bioveta Serum Gonadotrophin for Injection SWOT Analysis
11.4.9 Bioveta Recent Developments
11.5 Ningbo Sansheng Biological Technology
11.5.1 Ningbo Sansheng Biological Technology Corporation Information
11.5.2 Ningbo Sansheng Biological Technology Business Overview
11.5.3 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.5.4 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Sales by Product in 2024
11.5.6 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Sales by Application in 2024
11.5.7 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection Sales by Geographic Area in 2024
11.5.8 Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection SWOT Analysis
11.5.9 Ningbo Sansheng Biological Technology Recent Developments
11.6 Ningbo Second Hormone Factory
11.6.1 Ningbo Second Hormone Factory Corporation Information
11.6.2 Ningbo Second Hormone Factory Business Overview
11.6.3 Ningbo Second Hormone Factory Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.6.4 Ningbo Second Hormone Factory Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Ningbo Second Hormone Factory Recent Developments
11.7 Chifeng Bo-en Pharmaceutical
11.7.1 Chifeng Bo-en Pharmaceutical Corporation Information
11.7.2 Chifeng Bo-en Pharmaceutical Business Overview
11.7.3 Chifeng Bo-en Pharmaceutical Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.7.4 Chifeng Bo-en Pharmaceutical Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Chifeng Bo-en Pharmaceutical Recent Developments
11.8 Guangzhou Vbio-Pharma
11.8.1 Guangzhou Vbio-Pharma Corporation Information
11.8.2 Guangzhou Vbio-Pharma Business Overview
11.8.3 Guangzhou Vbio-Pharma Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.8.4 Guangzhou Vbio-Pharma Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Guangzhou Vbio-Pharma Recent Developments
11.9 JALLY
11.9.1 JALLY Corporation Information
11.9.2 JALLY Business Overview
11.9.3 JALLY Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.9.4 JALLY Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 JALLY Recent Developments
11.10 Ningbo Creator Animal Pharmaceutical
11.10.1 Ningbo Creator Animal Pharmaceutical Corporation Information
11.10.2 Ningbo Creator Animal Pharmaceutical Business Overview
11.10.3 Ningbo Creator Animal Pharmaceutical Serum Gonadotrophin for Injection Product Models, Descriptions and Specifications
11.10.4 Ningbo Creator Animal Pharmaceutical Serum Gonadotrophin for Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Ningbo Creator Animal Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Serum Gonadotrophin for Injection Industry Chain
12.2 Serum Gonadotrophin for Injection Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Serum Gonadotrophin for Injection Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Serum Gonadotrophin for Injection Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Serum Gonadotrophin for Injection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Serum Gonadotrophin for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
MSD Animal Health
Ceva Santé Animale
Bioveta
Ningbo Second Hormone Factory
Syntex SA
Ningbo Sansheng Biological Technology
Chifeng Bo-en Pharmaceutical
Guangzhou Vbio-Pharma
JALLY
Ningbo Creator Animal Pharmaceutical
List of Tables
 Table 1. Global Serum Gonadotrophin for Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Serum Gonadotrophin for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Serum Gonadotrophin for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Serum Gonadotrophin for Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Serum Gonadotrophin for Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Serum Gonadotrophin for Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Serum Gonadotrophin for Injection Sales by Region (2020-2025) & (K Units)
 Table 8. Global Serum Gonadotrophin for Injection Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Serum Gonadotrophin for Injection Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Serum Gonadotrophin for Injection Sales Share by Manufacturers (2020-2025)
 Table 12. Global Serum Gonadotrophin for Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Serum Gonadotrophin for Injection Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Serum Gonadotrophin for Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Serum Gonadotrophin for Injection as of 2024)
 Table 16. Global Serum Gonadotrophin for Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Serum Gonadotrophin for Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Serum Gonadotrophin for Injection Manufacturing Base and Headquarters
 Table 19. Global Serum Gonadotrophin for Injection Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Serum Gonadotrophin for Injection Sales by Type (2020-2025) & (K Units)
 Table 23. Global Serum Gonadotrophin for Injection Sales by Type (2026-2031) & (K Units)
 Table 24. Global Serum Gonadotrophin for Injection Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Serum Gonadotrophin for Injection Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Serum Gonadotrophin for Injection ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Serum Gonadotrophin for Injection Sales by Application (2020-2025) & (K Units)
 Table 29. Global Serum Gonadotrophin for Injection Sales by Application (2026-2031) & (K Units)
 Table 30. Serum Gonadotrophin for Injection High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Serum Gonadotrophin for Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Serum Gonadotrophin for Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Serum Gonadotrophin for Injection ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Serum Gonadotrophin for Injection Growth Accelerators and Market Barriers
 Table 37. North America Serum Gonadotrophin for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Serum Gonadotrophin for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Serum Gonadotrophin for Injection Growth Accelerators and Market Barriers
 Table 40. Europe Serum Gonadotrophin for Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Serum Gonadotrophin for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Serum Gonadotrophin for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Serum Gonadotrophin for Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Serum Gonadotrophin for Injection Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Serum Gonadotrophin for Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Serum Gonadotrophin for Injection Investment Opportunities and Key Challenges
 Table 47. Central and South America Serum Gonadotrophin for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Serum Gonadotrophin for Injection Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Serum Gonadotrophin for Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. MSD Animal Health Corporation Information
 Table 51. MSD Animal Health Description and Major Businesses
 Table 52. MSD Animal Health Product Models, Descriptions and Specifications
 Table 53. MSD Animal Health Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. MSD Animal Health Sales Value Proportion by Product in 2024
 Table 55. MSD Animal Health Sales Value Proportion by Application in 2024
 Table 56. MSD Animal Health Sales Value Proportion by Geographic Area in 2024
 Table 57. MSD Animal Health Serum Gonadotrophin for Injection SWOT Analysis
 Table 58. MSD Animal Health Recent Developments
 Table 59. Ceva Santé Animale Corporation Information
 Table 60. Ceva Santé Animale Description and Major Businesses
 Table 61. Ceva Santé Animale Product Models, Descriptions and Specifications
 Table 62. Ceva Santé Animale Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Ceva Santé Animale Sales Value Proportion by Product in 2024
 Table 64. Ceva Santé Animale Sales Value Proportion by Application in 2024
 Table 65. Ceva Santé Animale Sales Value Proportion by Geographic Area in 2024
 Table 66. Ceva Santé Animale Serum Gonadotrophin for Injection SWOT Analysis
 Table 67. Ceva Santé Animale Recent Developments
 Table 68. Syntex SA Corporation Information
 Table 69. Syntex SA Description and Major Businesses
 Table 70. Syntex SA Product Models, Descriptions and Specifications
 Table 71. Syntex SA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Syntex SA Sales Value Proportion by Product in 2024
 Table 73. Syntex SA Sales Value Proportion by Application in 2024
 Table 74. Syntex SA Sales Value Proportion by Geographic Area in 2024
 Table 75. Syntex SA Serum Gonadotrophin for Injection SWOT Analysis
 Table 76. Syntex SA Recent Developments
 Table 77. Bioveta Corporation Information
 Table 78. Bioveta Description and Major Businesses
 Table 79. Bioveta Product Models, Descriptions and Specifications
 Table 80. Bioveta Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Bioveta Sales Value Proportion by Product in 2024
 Table 82. Bioveta Sales Value Proportion by Application in 2024
 Table 83. Bioveta Sales Value Proportion by Geographic Area in 2024
 Table 84. Bioveta Serum Gonadotrophin for Injection SWOT Analysis
 Table 85. Bioveta Recent Developments
 Table 86. Ningbo Sansheng Biological Technology Corporation Information
 Table 87. Ningbo Sansheng Biological Technology Description and Major Businesses
 Table 88. Ningbo Sansheng Biological Technology Product Models, Descriptions and Specifications
 Table 89. Ningbo Sansheng Biological Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Ningbo Sansheng Biological Technology Sales Value Proportion by Product in 2024
 Table 91. Ningbo Sansheng Biological Technology Sales Value Proportion by Application in 2024
 Table 92. Ningbo Sansheng Biological Technology Sales Value Proportion by Geographic Area in 2024
 Table 93. Ningbo Sansheng Biological Technology Serum Gonadotrophin for Injection SWOT Analysis
 Table 94. Ningbo Sansheng Biological Technology Recent Developments
 Table 95. Ningbo Second Hormone Factory Corporation Information
 Table 96. Ningbo Second Hormone Factory Description and Major Businesses
 Table 97. Ningbo Second Hormone Factory Product Models, Descriptions and Specifications
 Table 98. Ningbo Second Hormone Factory Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Ningbo Second Hormone Factory Recent Developments
 Table 100. Chifeng Bo-en Pharmaceutical Corporation Information
 Table 101. Chifeng Bo-en Pharmaceutical Description and Major Businesses
 Table 102. Chifeng Bo-en Pharmaceutical Product Models, Descriptions and Specifications
 Table 103. Chifeng Bo-en Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Chifeng Bo-en Pharmaceutical Recent Developments
 Table 105. Guangzhou Vbio-Pharma Corporation Information
 Table 106. Guangzhou Vbio-Pharma Description and Major Businesses
 Table 107. Guangzhou Vbio-Pharma Product Models, Descriptions and Specifications
 Table 108. Guangzhou Vbio-Pharma Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. Guangzhou Vbio-Pharma Recent Developments
 Table 110. JALLY Corporation Information
 Table 111. JALLY Description and Major Businesses
 Table 112. JALLY Product Models, Descriptions and Specifications
 Table 113. JALLY Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. JALLY Recent Developments
 Table 115. Ningbo Creator Animal Pharmaceutical Corporation Information
 Table 116. Ningbo Creator Animal Pharmaceutical Description and Major Businesses
 Table 117. Ningbo Creator Animal Pharmaceutical Product Models, Descriptions and Specifications
 Table 118. Ningbo Creator Animal Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Ningbo Creator Animal Pharmaceutical Recent Developments
 Table 120. Key Raw Materials Distribution
 Table 121. Raw Materials Key Suppliers
 Table 122. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 123. Milestones in Production Technology Evolution
 Table 124. Distributors List
 Table 125. Market Trends and Market Evolution
 Table 126. Market Drivers and Opportunities
 Table 127. Market Challenges, Risks, and Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. Serum Gonadotrophin for Injection Product Picture
 Figure 2. Global Serum Gonadotrophin for Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 1000 IU/Unit Product Picture
 Figure 4. 5000 IU/Unit Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Serum Gonadotrophin for Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Pig
 Figure 8. Cattle
 Figure 9. Sheep
 Figure 10. Horse
 Figure 11. Other Animals
 Figure 12. Serum Gonadotrophin for Injection Report Years Considered
 Figure 13. Global Serum Gonadotrophin for Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Serum Gonadotrophin for Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Serum Gonadotrophin for Injection Revenue Market Share by Region (2020-2031)
 Figure 17. Global Serum Gonadotrophin for Injection Sales (2020-2031) & (K Units)
 Figure 18. Global Serum Gonadotrophin for Injection Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 19. Global Serum Gonadotrophin for Injection Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Serum Gonadotrophin for Injection Sales Volume Market Share in 2024
 Figure 21. Global Serum Gonadotrophin for Injection Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. 1000 IU/Unit Revenue Market Share by Manufacturer in 2024
 Figure 24. 5000 IU/Unit Revenue Market Share by Manufacturer in 2024
 Figure 25. Others Revenue Market Share by Manufacturer in 2024
 Figure 26. Global Serum Gonadotrophin for Injection Sales Market Share by Type (2020-2031)
 Figure 27. Global Serum Gonadotrophin for Injection Revenue Market Share by Type (2020-2031)
 Figure 28. Global Serum Gonadotrophin for Injection Sales Market Share by Application (2020-2031)
 Figure 29. Global Serum Gonadotrophin for Injection Revenue Market Share by Application (2020-2031)
 Figure 30. North America Serum Gonadotrophin for Injection Sales YoY (2020-2031) & (K Units)
 Figure 31. North America Serum Gonadotrophin for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers Serum Gonadotrophin for Injection Sales Revenue (US$ Million) in 2024
 Figure 33. North America Serum Gonadotrophin for Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 34. North America Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America Serum Gonadotrophin for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 36. North America Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe Serum Gonadotrophin for Injection Sales YoY (2020-2031) & (K Units)
 Figure 41. Europe Serum Gonadotrophin for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers Serum Gonadotrophin for Injection Sales Revenue (US$ Million) in 2024
 Figure 43. Europe Serum Gonadotrophin for Injection Sales Volume (K Units) by Type (2020-2031)
 Figure 44. Europe Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe Serum Gonadotrophin for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 46. Europe Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 48. France Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Serum Gonadotrophin for Injection Sales YoY (2020-2031) & (K Units)
 Figure 53. Asia-Pacific Serum Gonadotrophin for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers Serum Gonadotrophin for Injection Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific Serum Gonadotrophin for Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 56. Asia-Pacific Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific Serum Gonadotrophin for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 58. Asia-Pacific Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 63. India Serum Gonadotrophin for Injection Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America Serum Gonadotrophin for Injection Sales YoY (2020-2031) & (K Units)
 Figure 65. Central and South America Serum Gonadotrophin for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers Serum Gonadotrophin for Injection Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America Serum Gonadotrophin for Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 68. Central and South America Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America Serum Gonadotrophin for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 70. Central and South America Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil Serum Gonadotrophin for Injection Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina Serum Gonadotrophin for Injection Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa Serum Gonadotrophin for Injection Sales YoY (2020-2031) & (K Units)
 Figure 74. Middle East and Africa Serum Gonadotrophin for Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers Serum Gonadotrophin for Injection Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa Serum Gonadotrophin for Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 77. South America Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa Serum Gonadotrophin for Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 79. Middle East and Africa Serum Gonadotrophin for Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries Serum Gonadotrophin for Injection Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey Serum Gonadotrophin for Injection Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt Serum Gonadotrophin for Injection Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa Serum Gonadotrophin for Injection Revenue (2020-2025) & (US$ Million)
 Figure 84. Serum Gonadotrophin for Injection Industry Chain Mapping
 Figure 85. Regional Serum Gonadotrophin for Injection Manufacturing Base Distribution (%)
 Figure 86. Global Serum Gonadotrophin for Injection Production Market Share by Region (2020-2031)
 Figure 87. Serum Gonadotrophin for Injection Production Process
 Figure 88. Regional Serum Gonadotrophin for Injection Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Pregnant Mare Serum Gonadotropin PMSG Market Research Report 2025
Global Equine Chorionic Gonadotropin eCG for Injection Market Research Report 2024
Global Equine Chorionic Gonadotropin eCG Market Research Report 2024
Global Follicle Stimulating Hormone FSH Injections Market Research Report 2024
Global Recombinant FSH Injections Market Research Report 2024
Global Follicle Stimulating Hormone Market Research Report 2025
Global Injectable Fertility Medications Market Research Report 2024
Gonadotropin releasing Hormone Agonist Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Gonadotropin releasing Hormone Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GnRH Agonist Market Research Report 2024
Global Injectable IVF Medications Market Research Report 2024
Global Menotropin Market Research Report 2024
Global Growth Hormone Injection Market Research Report 2024
Global Chorionic Gonadotrophin Market Research Report 2024
Recombinant Human Follicle stimulating Hormone Market
Global Recombinant Human Follicle Stimulating Hormone Injection Market Research Report 2024
Global Chorionic Gonadotropin for Injection Market Research Report 2025
Human Chorionic Gonadotropin HCG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Posterior Pituitary for Injection Market Research Report 2024
Follitropin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions